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Abstract
Objective: To examine the risk of stroke in relation to
quality of hypertension control in routine general
practice across an entire health district.
Design: Population based matched case›control
study.
Setting: East Lancashire Health District with a
participating population of 388 821 aged ≤ 80.
Subjects: Cases were patients under 80 with their first
stroke identified from a population based stroke
register between 1 July 1994 and 30 June 1995. For
each case two controls matched with the case for age
and sex were selected from the same practice register.
Hypertension was defined as systolic blood pressure
≥ 160 mm Hg or diastolic blood pressure ≥ 95 mm Hg,
or both, on at least two occasions within any three
month period or any history of treatment with
antihypertensive drugs.
Main outcome measures: Prevalence of hypertension
and quality of control of hypertension (assessed by
using the mean blood pressure recorded before
stroke) and odds ratios of stroke (derived from
conditional logistic regression).
Results: Records of 267 cases and 534 controls were
examined; 61% and 42% of these subjects respectively
were hypertensive. Compared with non›hypertensive
subjects hypertensive patients receiving treatment
whose average pre›event systolic blood pressure was
controlled to < 140 mm Hg had an adjusted odds
ratio for stroke of 1.3 (95% confidence interval 0.6 to
2.7). Those fairly well controlled (140›149 mm Hg),
moderately controlled (150›159 mm Hg), or poorly
controlled ( ≥ 160 mm Hg) or untreated had
progressively raised odds ratios of 1.6, 2.2, 3.2, and 3.5
respectively. Results for diastolic pressure were similar;
both were independent of initial pressures before
treatment. Around 21% of strokes were thus
attributable to inadequate control with treatment, or
46 first events yearly per 100 000 population aged
40›79.
Conclusions: Risk of stroke was clearly related to
quality of control of blood pressure with treatment. In
routine practice consistent control of blood pressure
to below 150/90 mm Hg seems to be required for
optimal stroke prevention.
Introduction
The continuous relation between the blood pressure
level and risk of subsequent stroke provides much of
the impetus for measuring blood pressure in primary
care.1›5 Similarly, the benefit in reducing stroke in trials
of treatment is that predicted from observational
studies.6 However, to what extent that potential benefit
is realised in routine clinical practice is much less clear.
In hospital attenders blood pressure achieved with
treatment rather than the initial blood pressure deter›
mined the risk of stroke.7 8 Few studies in routine
primary care have examined either the question of
what constitutes “hypertension” in relation to stroke or
the quality of control of previously treated blood pres›
sure in stroke cases.9›13 Both factors are likely to
account for much of the population stroke risk that
should be preventable on current evidence. Using a
population based stroke register maintained fully for
one calendar year, we tried to determine the relation
between the risk of stroke and the quality of control of
hypertension in routine general practice across an
entire health district. The study setting in the commu›
nity also allowed those stroke patients not admitted
nor ever seen at a hospital to be included, so providing
a representative sample in which to examine the link
between stroke and blood pressure.
Subjects and methods
The study was in east Lancashire, a health district
including the towns of Blackburn and Burnley, with a
total population of 534 287 in the 1995 general
practice register. Stroke cases were identified from a
district wide, population based stroke register between
1 July 1994 and 30 June 1995 with 103 of 118 general
practices participating. Cases from a further 10 (8%)
practices were inconsistently notified or verified, so the
total practice inclusion rate was 79% (93 practices).
These practices served a population of 405 272, of
whom 388 821 were under 80 years of age (161 978
aged 40›79 years), the denominator for the study.
A case›control design was used, restricted to
patients aged under 80 with their first ever strokes
because strokes below this age can be regarded as
preventable.14 15 The main hypothesis was that there
was a difference in risk of stroke between hypertensive
patients who were treated but not well controlled and
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those well controlled as well as subjects who were non›
hypertensive. We used an arbitrary definition of hyper›
tension ( ≥ 160/95 mm Hg)16 likely to be in routine use
before the study and assumed the prevalence of treated
hypertensive patients who were not well controlled
( ≥ 150/90 mm Hg) to be 14% of the population aged
under 80. Applying these variables showed that 220
cases and 440 controls were required to detect an odds
ratio of 2 compared with non›hypertensive subjects
with 80% power when using a two sided á level of 5%.
For each case two controls matched with the case for
sex and age (within two years) and without a history of
stroke were selected from the same practice register.
All blood pressure readings with the dates and
drug treatment before the index date of stroke were
recorded from the notes or the practice computer. The
classification of who met definitions of “hypertension”
was conducted on computer blind to case or control
status. Each set of notes was also systematically
searched for other known prespecified risk factors.
Hypertension was defined as above blood pressure
levels on two or more occasions within any three
month period or a history of antihypertensive treat›
ment at any time. Baseline blood pressure was either
the average of these two readings if they met the cri›
teria for hypertension or the blood pressure immedi›
ately before treatment first started if the criteria had
not been met at that time. The quality of hypertension
control was assessed by using the mean blood pressure
recorded in the last one, three, and five years before the
index date. Treated hypertension was defined from the
documented use (prescription) of drugs appropriate
for hypertension.
Analysis—Matched case›control analysis was by con›
ditional logistic regression,17 odds ratios being used to
determine associations. Population attributable risk
was calculated as the difference between overall risk in
the population and the population risk that might be
achieved if blood pressure were maintained at the “well
controlled” level, divided by overall risk in the popula›
tion. This was calculated in the population aged over
40 years because strokes are rare in people under 40.
Results
Stroke register—Of 1233 notifications from multiple
sources, 932 were confirmed strokes. Of these, 642
were first ever strokes, 363 occurring in people under
80 (355 aged 40›79 years). Only the first 267 (74%) of
the 363 formed the cases, as this number met power
requirements and resources did not allow collection of
two controls for the remaining 96 cases. However,
these 96 cases were similar to the cases included: case
fatality at 28 days was 25.1% for the 267 cases
compared with 25.3% for the 363; age and sex
distribution was also similar.
Prevalence—Comparing the characteristics of cases
and controls showed a significantly higher prevalence
of smoking, transient ischaemic attack, atrial fibril›
lation, and diabetes in cases (table 1). Occasional
Table 1 Characteristics of cases and controls. Except where stated otherwise figures are numbers (percentages) of subjects
Characteristic
Cases
(n=267)
Controls
(n=534)
Crude odds ratio
(95% confidence
interval)
Adjusted odds
ratio (95%
confidence
interval)†
Mean (SD), median age (years) 67 (9.9),
69.0
67 (9.9),
69.5
Mean (SD), median systolic/diastolic blood pressure in last
five years (mm Hg)
151.0 (19.4),
151.0/85.1 (9.4),
85.0
145.6 (17.5),
144.5/82.6 (8.0),
82.5
Non›smokers 72 (36.4) 203 (53.7) 1 1
Former smokers 48 (24.2) 79 (20.9) 1.7 (1.1 to 2.7) 1.5 (0.9 to 2.6)
Current smokers:
<20 cigarettes/day 46 (23.2) 56 (14.8) 2.4 (1.5 to 3.9) 2.7 (1.5 to 4.9)**
≥20 cigarettes/day 22 (11.1) 23 (6.1) 2.7 (1.4 to 5.3) 2.9 (1.4 to 6.3)**
Amount unknown 10 (5.1) 17 (4.5) 1.6 (0.7 to 3.7) 1.4 (0.5 to 3.9)
Missing data on smoking 69 (25.8) 156 (29.2) 1.2 (0.8 to 1.9) 1.4 (0.8 to 2.5)
Non›drinkers 52 (44.5) 71 (22.8) 1 1
Occasional drinkers 30 (19.4) 96 (30.8) 0.4 (0.2 to 0.7) 0.3 (0.2 to 0.6)**
Regular drinkers:
<20 U/week 39 (25.2) 108 (34.6) 0.5 (0.3 to 0.8) 0.4 (0.2 to 0.7)**
20›29 U/week 14 (9.0) 19 (6.1) 1.0 (0.5 to 2.2) 0.9 (0.4 to 2.2)
≥30 U/week 11 (7.1) 8 (2.6) 2.0 (0.7 to 5.2) 1.9 (0.6 to 5.8)
Amount unknown 9 (5.8) 10 (3.2) 1.2 (0.5 to 3.3) 1.4 (0.4 to 4.1)
Missing data on alcohol intake 112 (41.9) 222 (41.6) 0.7 (0.4 to 1.5) 0.8 (0.4 to 1.5)
Past medical history of:
Transient ischaemic attack 29 (10.9) 14 (2.6) 4.6 (2.3 to 9.1) 4.1 (1.9 to 8.7)**
Myocardial infarction 28 (10.5) 32 (6.0) 1.9 (1.1 to 3.2) 1.3 (0.6 to 2.7)
Atrial fibrillation 32 (12.0) 12 (2.2) 6.6 (3.2 to 14.0) 5.4 (2.3 to 12.5)**
Diabetes 44 (16.5) 37 (6.9) 2.4 (1.6 to 3.8) 2.0 (1.2 to 3.4)**
Angina 53 (19.9) 73 (13.7) 1.6 (1.1 to 2.4) 0.9 (0.5 to 1.5)
Obesity 31 (11.6) 31 (5.8) 2.2 (1.3 to 3.8) 1.4 (0.7 to 2.6)
Migraine 23 (8.6) 32 (6.0) 1.5 (0.8 to 2.6) 1.2 (0.6 to 2.4)
Family history of stroke 18 (6.7) 44 (8.2) 0.8 (0.5 to 1.4) 0.9 (0.4 to 1.8)
Family history of myocardial infarction 27 (10.1) 47 (8.8) 1.2 (0.7 to 1.9) 1.2 (0.7 to 2.2)
†Odds ratios were adjusted for smoking, alcohol intake, past medical history of transient ischaemic attack, myocardial infarction, atrial fibrillation, diabetes, angina,
obesity, migraine, family history of stroke, and family history of myocardial infarction.
**P<0.05.
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drinking and regular light drinking had protective
effects. There was no significant impact of other
recorded factors. Sixty one per cent (157/258) of
stroke cases were hypertensive compared with 42%
(212/499) of controls. The adjusted odds ratio for
stroke due to hypertension was 2.5 (95% confidence
interval 1.7 to 3.9). The prevalence of hypertension
increased with age and was higher in women.
Effects of blood pressure control—Compared with non›
hypertensive subjects, hypertensive patients whose
average systolic blood pressure in the last five years
before the index date was well controlled to below 140
mm Hg or fairly well controlled to 140›149 mm Hg
had insignificantly raised odds ratios (table 2).
Hypertensive patients whose systolic blood pressure
was moderately controlled (150›159 mm Hg) or poorly
controlled ( ≥ 160 mm Hg) or untreated had progres›
sively raised risks. Odds ratios for well controlled
diastolic pressure ( < 85 mm Hg), fairly well controlled
diastolic pressure (85›89 mm Hg), moderately control›
led diastolic pressure (90›94 mm Hg), and poorly con›
trolled ( ≥ 95 mm Hg) and untreated diastolic pressure
were generally similar to those for systolic pressure in
size and trend (fig 1). Risk was also similar for blood
pressure levels achieved in the last one and three years
before the index date (data not shown) but was strong›
est and most consistent in the last five years. Patients
with no blood pressure readings recorded in the last
five years had over five times the risk for stroke
with wide confidence intervals. Systolic and diastolic
blood pressures were highly correlated. After adjust›
ing each for the effect of the other adjusted odds
ratios for systolic pressures of 150›159 mm Hg and
≥ 160 mm Hg were significantly raised at 1.7 and
2.0 compared with non›hypertensive subjects and for
diastolic pressures ≥ 95 mm Hg were 5.4.
Baseline blood pressure—The risk of stroke with
achieved blood pressure was also examined in relation
to baseline pressure before treatment (table 3). This
showed a trend of increasing risk with poor control
(that is, a trend across rows) in almost all groups
Table 2 Relation between risk of stroke and blood pressure control in last five years before stroke
Category of systolic blood pressure
Mean (SD)
systolic pressure in
last five years (mm Hg)
No of cases
(n=267)
No of controls
(n=534)
Crude odds ratio
(95% confidence interval)
Adjusted odds ratio†
(95% confidence interval) P value
Not hypertensive 140.0 (17.1) 101 287 1 1
Treated hypertensive patients’ blood pressure in last five years before index date (mm Hg):
<140 131.4 (7.7) 23 43 1.7 (0.9 to 3.1) 1.3 (0.6 to 2.7) 0.559
140›149 144.3 (2.8) 22 41 1.9 (1.0 to 3.5) 1.6 (0.7 to 3.3) 0.251
150›159 154.5 (2.7) 31 38 2.7 (1.6 to 4.7) 2.2 (1.1 to 4.4) 0.023
≥160 164.3 (2.8) 49 55 3.0 (1.8 to 4.9) 3.2 (1.8 to 5.6) <0.001
Hypertensive but untreated 178.8 (9.1) 28 32 2.9 (1.6 to 5.3) 3.5 (1.8 to 6.9) <0.001
No blood pressure readings in
period
4 3 4.0 (0.9 to 19.0) 5.6 (1.1 to 28.2) 0.036
No blood pressure record at all 9 35 0.7 (0.3 to 1.6) 0.9 (0.4 to 2.1) 0.771
†Adjusted as in table 1. Significance of trend in odds ratios for systolic blood pressure P<0.01.
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Fig 1 Odds ratios for stroke in relation to average diastolic blood
pressures achieved with treatment in last five years before stroke
(bars are 95% confidence intervals)
Table 3 Effect of achieved blood pressure in treated hypertensive patients in last five years before stroke and baseline blood pressure.
Results expressed as odds ratios (95% confidence intervals) adjusted as in table 1 (numbers of cases, controls). Non›hypertensive
subjects served as reference
Baseline
systolic blood
pressure
(mm Hg)
Systolic blood pressure in last five years (mm Hg)
Baseline
diastolic blood
pressure
(mm Hg)
Diastolic blood pressure in last five years (mm Hg)
< 150 150›159 ≥ 160 < 85 85›89 ≥ 90
<160 1.5 (0.7 to 3.3)
(20, 32)
1.4 (2.2 to 8.3)
(3, 6)
3.1 (0.5 to 21.3)
(3, 4)
<95 2.0 (1.0 to 4.1)
(31, 40)
2.1 (0.9 to 5.1)
(19, 18)
3.4 (0.7 to 17.5)
(4, 6)
160›169 1.0 (0.4 to 2.6)
(11, 28)
2.0 (0.5 to 7.0)
(6, 10)
4.8 (1.4 to 16.4)
(7, 7)
95›99 2.2 (0.7 to 7.4)
(8, 11)
0.8 (0.2 to 2.9)
(5, 13)
1.1 (0.2 to 4.8)
(3, 12)
170›179 1.3 (0.4 to 4.3)
(8, 14)
3.0 (1.0 to 8.7)
(12, 10)
6.7 (2.5 to 17.9)
(18, 11)
100›104 0.8 (0.2 to 3.0)
(5, 18)
2.0 (0.6 to 7.1)
(7, 9)
8.9 (1.5 to 51.1)
(7, 5)
≥180 1.5 (0.4 to 6.1)
(6, 10)
1.6 (0.5 to 4.7)
(10, 12)
1.7 (0.8 to 3.7)
(21, 33)
≥105 0.6 (0.2 to 2.0)
(7, 21)
2.1 (0.6 to 7.0)
(7, 10)
5.5 (2.3 to 13.2)
(22, 14)
Odds ratios for 60 subjects with untreated blood pressure and 51 with no readings (including seven without blood pressure readings in last five years) were 3.4 (1.7
to 6.7) and 1.3 (0.6 to 2.7) for systolic blood pressure, and 3.2 (1.6 to 6.2) and 1.2 (0.6 to 2.5) for diastolic blood pressure respectively.
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defined by their baseline pressure. However, there
was no consistent trend from low to high baseline
pressures (that is, down columns), suggesting that after
treatment baseline pressures no longer influenced the
risk of stroke. To test this proposition more formally
models which included achieved and baseline blood
pressures were fitted. Adding the achieved pressure
variable to a model including baseline significantly
improved the fit (P = 0.04 for systolic; P < 0.001 for
diastolic) whereas adding the baseline pressure
variable to a model including achieved pressure did
not (P = 0.192; P = 0.388). We also considered whether
the effect of achieved blood pressure varied with the
baseline pressure by fitting an interaction variable to
the model; this was not significant (P = 0.282; P = 0.146).
Population attributable risk—When moderately con›
trolled, poorly controlled, or untreated hypertension
was reduced to well controlled levels ( < 150/90 mm Hg)
population attributable risk was 21% in the population
aged 40›79 years after adjusting for the total age and sex
specific population. Thus every year 75 (21% of 355) first
strokes in a population of 161 978 aged 40›79 years
could have been prevented by good control, a rate of
some 46 events per 100 000 population aged 40›79
years. The number of poorly controlled and untreated
hypertensive patients requiring good control to below
150/90 mm Hg (that is, the “numbers needed to treat”)
to prevent one stroke was 86 for five years in the popula›
tion aged 40›79 years.
Discussion
This population based case›control study examined the
relation between the risk of stroke and the quality of
hypertension control in people aged under 80. To our
knowledge this is the first study to do so after ascertain›
ing all stroke events in routine care in a whole commu›
nity rather than selected (hospital or volunteer) cases.
The study had potential limitations. Firstly, clinical
diagnosis of stroke made by doctors was usually not
confirmed by computed tomography. The clinical diag›
nosis of a stroke having occurred or not is reliable.18 19 As
the diagnosis of stroke types without computed tomog›
raphy is unreliable,19 all types of stroke were combined.
Secondly, though hypertension data were missing in
only 5% of notes, the proportion missing for smoking
and alcohol consumption was large. However, we
analysed the effect of these missing values, which
illustrated their potential risks. Our results also showed
an impact on stroke from other major risk factors—
twofold for known diabetes and nearly threefold for
smoking, similar to results of cohort studies.20 21
Though hypertension detection was much better
than the rule of halves, achieving adequate control for
patients so detected was not. The rule was operating in
the United Kingdom in the 1980s11 22 and continues in
the most recent analyses in terms of control.23 24 This is
particularly important for communities at high cardio›
vascular risk with most to gain—for instance, older
adults and particular ethnic groups. Trial results have
shown unequivocal evidence in favour of hypertension
treatment reducing all cardiovascular events, dating
back to 1985 for older adults,25›30 illustrating the dif›
ficulty of convincing doctors and possibly patients that
not just treatment but optimal control is what matters.
Over half of the hypertensive stroke cases (51%;
80/157) had either untreated or poorly controlled
blood pressure in the last five years before the index
date compared with 42% (88/212) of non›stroke
hypertensive patients. The gap between routine
practice and evidence from other studies may partly be
due to the doctors’ beliefs—for example, that these were
research populations and therefore less relevant to
their practice—or due to the slow acceptance of new
knowledge. As our study was based on practitioners’
own medical records in routine primary care the
results would be highly relevant not only to them but
also to health purchasers, as general practitioners are
the gatekeepers of medical care in the NHS.
The most appropriate way of expressing these
results for routine practice has been discussed.31 32 For
primary care teams and purchasers perhaps the most
useful is in relation to the age group at high risk—say,
40›79 years. For those hypertensive patients in our
study who were receiving treatment, achieving good
control to below 150/90 mm Hg reduced the risk of
stroke by 53% with a continuing favourable trend
below this level. Some 46 first strokes per 100 000
population aged 40›79 years could be avoided yearly.
Hence the number needed to treat was 86 such hyper›
tensive patients required to have changed from poorly
controlled to well controlled blood pressure levels
(maintained at that average level over five years) to
have prevented one stroke, and within this age range
the older the patient the greater the absolute benefit.
Finally, other studies may have overestimated the
role of diastolic pressure by not adjusting for the
simultaneous systolic value1 2 5 6 and smoking.5 In a
recent large prospective study33 and an earlier study34
the impact of diastolic pressure on risk of stroke was
much reduced when systolic pressure was taken into
account. However, in our study the effect of one
pressure when adjusted for the other was still
impressive with the size of risk reduced only slightly.
Thus in routine practice our data suggest that,
independent of baseline level, blood pressure achieved
with treatment in the few years before a stroke was the
Key messages
x A case›control study based on the community
stroke register and practice records showed a
prevalence of hypertension of 61% for stroke
patients and 42% in controls
x Quality of control of blood pressure was clearly
related to the risk of stroke, independent of
baseline blood pressure
x Detection and treatment rates of hypertension
were high but control of blood pressure to
below 150/90 mm Hg in treated hypertensive
patients was only 33% in cases and 42% in
controls
x When achieving optimal control of
hypertension (to < 150/90 mm Hg) in the most
at risk and treatable age range (40›79 years)
86 hypertensive patients currently not well
controlled need to be treated over five years to
prevent one stroke
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important predicting factor. This has important impli›
cations for hypertension management policy, requir›
ing patients with hypertension to have their blood
pressure treated and maintained below the specified
target levels rather than just being given treatment.
Conclusion
The risk of stroke was clearly related to the quality of
blood pressure control with treatment. In routine prac›
tice, together with detecting untreated subjects, con›
sistent control to target levels below 150/90 mm Hg
rather than just starting treatment seems to be
required for optimal stroke prevention.
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ONE HUNDRED YEARS AGO
The bicycle and the appendix
The bicycle is taking the place of the cigarette as a
pathological scapegoat. When so heavy and so complex a
burden of diseases has been laid upon it, one more might
seem to be of little importance, were it not that this last
straw is—appendicitis. Yet as everyone rides a bicycle
nowadays, and as (if we may believe some modern
authorities) nearly everyone has had or will have
appendicitis, the wonder is that the connection between
the two series of phenomena has not been perceived
sooner. The discovery, it is scarcely necessary to say, comes
from America, where there is, we are assured, a “boom” in
appendicitis. The condition is caused, it is alleged, by the
contractions, too frequent or too violent, of the
psoas›iliacus which bicycling involves. Hence results
contusion of the appendix, followed by the desquamation
of its mucous membrane; this makes a breach through
which infective agents find their way into the walls of the
appendix and set up inflammation. The straining caused
by going uphill makes the danger all the greater. In
persons who have already suffered from appendicitis,
bicycling may easily lead to rupture of adhesions and to
the development of an acute condition. Some little time
ago an American practitioner was so impressed by the
dangers to which the possession of a vermiform appendix
exposed mankind that he suggested its systematic removal
in childhood as a prophylactic measure. In these days,
when bicycling is so fashionable, this proposal may
perhaps have to be taken into serious consideration.
(BMJ 1897;i:872.)
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